Biotech NewsWhy Indivior (INDV) Just Raised 2025 Revenue Guidance to $1.18-$1.22B BioTech Health XNovember 6, 2025 Indivior plc (NASDAQ:INDV) is a global specialty biopharmaceutical company best known for pioneering science and access models in… 0 Shares 0 0 0 0 0 0 0